Prothena Reports Second Quarter 2021 Financial Results and Business HighlightsGlobeNewsWire • 08/05/21
Prothena (PRTA) Earnings Expected to Grow: What to Know Ahead of Q2 ReleaseZacks Investment Research • 07/29/21
Prothena: Underrated Player In Alzheimer's And Parkinson's Close To Securing First Drug ApprovalSeeking Alpha • 07/24/21
Prothena and Novo Nordisk Announce Acquisition Agreement for Prothena's ATTR Amyloidosis ProgrammeGlobeNewsWire • 07/12/21
Strength Seen in Prothena (PRTA): Can Its 7.3% Jump Turn into More Strength?Zacks Investment Research • 07/12/21
Prothena Announces Bristol Myers Squibb Opt-in of Anti-Tau PRX005 as the First Program from Global Neuroscience Research and Development CollaborationGlobeNewsWire • 06/24/21
Prothena to Participate in JMP Securities Life Sciences Conference on June 16GlobeNewsWire • 06/10/21
Prothena (PRTA) Up 78.2% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 06/10/21
Healthcare And Biotech Stocks Face Important Decisions, Remain A Promising InvestmentSeeking Alpha • 06/02/21
Prothena Announces Appointment of Sanjiv Patel, MBBS, to its Board of DirectorsGlobeNewsWire • 05/20/21